/Investor DB

Deerfield Management Company — 2023 Investments

4 investments dated 2023 · listed companies and verified rows first · show all

Actio Biosciences, Inc.actiobiosciences.comin𝕏Series A · Sep 2023 · $55M

Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions.

AI & Machine LearningBiotechDeep Tech

David Breckenridge(Founder)inDavid B. Goldstein(Founder)

Co-investorsCanaan PartnersDroia VenturesEcoR1 Capital

Corticacorticacare.cominApr 2023 · $75M

Cortica provides in-home, in-clinic, and telehealth neurological therapies for children with autism and developmental differences, integrating neurological, biomedical, behavioral, speech-language, and sensorimotor treatments.

Digital HealthHealthtechMedical DevicesSan Diego, US

Dr. Suzanne Goh(Founder)Neil Hattangadi(Co-Founder and Chief Executive Officer)inBriana Elvaiah(Executive Officer)inSuzanne Goh-Hattangadi(Founder)Suzanne Goh, MD, BCBA(Co-Founder and Chief Medical Officer)

BoardRyan Drant(Director)in

Co-investors.406 VenturesAIFAPERTURE Venture PartnersCVS Health VenturesEcho Health VenturesLongitude Capital+6 more

Platanusplatan.usinMay 2023 · $100M

Teambit analyzes code, meeting time, and interactions to measure and improve the performance of software development teams, delivering objective metrics.

AI & Machine LearningDeveloper ToolsSaaS

Paula Enei(Founder)in

Co-investorsGG Capital4BIO CapitalGeneral CatalystMRL Ventures FundNorwest Venture PartnersNovo Holdings

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Bitterroot Bio

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.